3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Neoplastic Cells, Circulating
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
Docetaxel
21
Radiosurgery
20
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
12
Goserelin
12
bicalutamide
11
Prednisone
9
Gonadotropin-Releasing Hormone
9
Abiraterone Acetate
9
enzalutamide
8
Surveys and Questionnaires
8
Radiotherapy, Intensity-Modulated
8
Brachytherapy
8
Blood Specimen Collection
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Triptorelin Pamoate
7
Multiparametric Magnetic Resonance Imaging
7
abiraterone
5
pembrolizumab
4
cabazitaxel
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Flutamide
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
Histamine H2 Antagonists
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled